Biomea Fusion Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Selling, General & Admin	27.61	23.59	20.92	13.67	1.66	0.1
Research & Development	123.71	102.55	62.71	28	3.67	1.09
Operating Expenses	151.32	126.14	83.63	41.67	5.33	1.2
Operating Income	-151.32	-126.14	-83.63	-41.67	-5.33	-1.2
Interest Expense	-	-	-	-	-	-0
Interest & Investment Income	7.32	8.88	1.95	0.62	0	-
EBT Excluding Unusual Items	-144.01	-117.25	-81.68	-41.05	-5.32	-1.2
Gain (Loss) on Sale of Investments	-0	-0	-0.14	-0.52	-	-
Pretax Income	-144.01	-117.26	-81.83	-41.57	-5.32	-1.2
Net Income	-144.01	-117.26	-81.83	-41.57	-5.32	-1.2
Net Income to Common	-144.01	-117.26	-81.83	-41.57	-5.32	-1.2
Shares Outstanding (Basic)	36	34	29	24	11	6
Shares Outstanding (Diluted)	36	34	29	24	11	6
Shares Change (YoY)	10.63%	16.52%	22.69%	126.51%	74.05%	-
EPS (Basic)	-4.00	-3.44	-2.80	-1.74	-0.51	-0.20
EPS (Diluted)	-4.00	-3.44	-2.80	-1.74	-0.51	-0.20
Free Cash Flow	-113.02	-99.96	-63.45	-38.61	-4.51	-1.28
Free Cash Flow Per Share	-3.14	-2.93	-2.17	-1.62	-0.43	-0.21
EBITDA	-149.63	-124.62	-82.94	-41.42	-5.32	-
D&A For EBITDA	1.7	1.52	0.69	0.25	0.01	-
EBIT	-151.32	-126.14	-83.63	-41.67	-5.33	-1.2

Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q